Novavax releases positive phase 3 trial data on its COVID-19 vaccine candidate; data show sharp increase in emergency department visits for attempted suicide; decrease in pediatric inpatient units throughout the country.
Data from a phase 3 trial testing Novavax’s COVID-19 vaccine in the United States and Mexico show that the candidate has a 90.4% overall efficacy, CNN reports. Further trial analyses are ongoing, and data will be submitted to peer-reviewed journals for publication. The study consisted of 29,960 adults across 113 sites. Novavax’s vaccine candidate is administered in 2 doses, scheduled 21 days apart. Results also indicate the vaccine is 100% effective against severe disease. According to the company, the candidate was 93.2% effective against variants of concern or interest.
New CDC data show that along with increased emergency department (ED) visits for mental health–related emergencies among adolescents during the pandemic, in May 2020, ED visits for suspected suicide attempts among those aged 12 to 17 years began to increase. The trend was especially prevalent among girls in this age range. Between February and March 2021, ED visits for suspected suicide attempts for girls were 50.6% higher compared with the same period in 2019. In comparison, the rate for boys during this time frame increased by 3.7%. Data were gleaned from the National Syndromic Surveillance Program.
Research published in Pediatrics found that pediatric inpatient unit capacity is decreasing in the United States, while access to inpatient care is declining for many children, especially those living in rural areas of the country. Investigators conducted a retrospective study of over 4700 US hospitals using data from the 2008-2018 American Hospital Association survey. Although results showed pediatric intensive care unit beds increased by 16% primarily at children’s hospitals, pediatric inpatient units fell by 19.1% in this time frame. Pediatric inpatient unit beds also decreased by 11.8%.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More